Hershkoviz R, Mor F, Miao H Q, Vlodavsky I, Lider O
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
J Autoimmun. 1995 Oct;8(5):741-50. doi: 10.1006/jaut.1995.0055.
The extravasation of activated T lymphocytes through blood vessel walls and their migration to inflammatory loci are associated with secretion of extracellular matrix (ECM)-degrading enzymes, such as heparanase, which degrades heparan sulfate (HS) moieties of the ECM. The HS-degrading activity of heparanase was found to be inhibited by HS and heparin. Since induction of experimental autoimmune encephalomyelitis (EAE) requires extravasation and migration of autoimmune T cells, degradation of ECM by heparanase is expected to be involved in induction of the disease. Herein, we examined whether laminarin sulfate, a polysulfated polysaccharide (PSS) isolated from the cell walls of seaweeds and subjected to chemical sulfation, could inhibit ECM degradation by mammalian heparanase, and could prevent EAE. PSS was a more potent inhibitor of heparanase-mediated degradation of ECM than heparin. In-vivo, PSS, injected once a week, inhibited the severity of actively-induced EAE in rats. However, inhibition of EAE was not due to an overall suppression of autoimmune T cells, since PSS enhanced the proliferation of myelin basic protein (MBP)-specific, encephalitogenic T cells. PSS-activated autoimmune T cells, but not MBP-activated cells, failed to induce EAE in recipient rats. Moreover, rats injected with PSS-activated T cells were resistant to induction of EAE by anti-MBP CD4+ T cells. Thus, PSS may have potential clinical applications in the treatment of autoimmune diseases.
活化的T淋巴细胞通过血管壁渗出并迁移至炎症部位,这与细胞外基质(ECM)降解酶的分泌有关,比如乙酰肝素酶,它能降解ECM的硫酸乙酰肝素(HS)部分。研究发现,HS和肝素可抑制乙酰肝素酶的HS降解活性。由于实验性自身免疫性脑脊髓炎(EAE)的诱发需要自身免疫性T细胞的渗出和迁移,因此预计乙酰肝素酶介导的ECM降解参与了该疾病的诱发过程。在此,我们研究了从海藻细胞壁分离并经化学硫酸化处理的多硫酸化多糖(PSS)硫酸昆布多糖,是否能够抑制哺乳动物乙酰肝素酶介导的ECM降解,并预防EAE。PSS对乙酰肝素酶介导的ECM降解的抑制作用比肝素更强。在体内,每周注射一次PSS可抑制大鼠主动诱导的EAE的严重程度。然而,EAE受到抑制并非由于自身免疫性T细胞受到全面抑制,因为PSS可增强髓鞘碱性蛋白(MBP)特异性致脑炎性T细胞的增殖。PSS激活的自身免疫性T细胞,而非MBP激活的细胞,无法在受体大鼠中诱发EAE。此外,注射了PSS激活的T细胞的大鼠对抗MBP CD4+ T细胞诱导的EAE具有抗性。因此,PSS在自身免疫性疾病的治疗中可能具有潜在的临床应用价值。